Morgan Stanley’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.16M Buy
314,410
+28,811
+10% +$198K ﹤0.01% 4650
2025
Q1
$823K Sell
285,599
-1,246,133
-81% -$3.59M ﹤0.01% 5098
2024
Q4
$7.2M Buy
1,531,732
+1,181,047
+337% +$5.55M ﹤0.01% 3676
2024
Q3
$1.25M Sell
350,685
-884,128
-72% -$3.16M ﹤0.01% 4912
2024
Q2
$7.66M Buy
1,234,813
+77,676
+7% +$482K ﹤0.01% 3534
2024
Q1
$10.9M Sell
1,157,137
-1,280,981
-53% -$12.1M ﹤0.01% 3281
2023
Q4
$16.5M Buy
2,438,118
+1,526,247
+167% +$10.3M ﹤0.01% 3514
2023
Q3
$4.05M Sell
911,871
-192,003
-17% -$852K ﹤0.01% 3899
2023
Q2
$3.64M Sell
1,103,874
-58,494
-5% -$193K ﹤0.01% 3992
2023
Q1
$3.31M Sell
1,162,368
-11,243
-1% -$32K ﹤0.01% 4108
2022
Q4
$8.54M Sell
1,173,611
-26,691
-2% -$194K ﹤0.01% 3228
2022
Q3
$9.71M Buy
1,200,302
+21,346
+2% +$173K ﹤0.01% 3014
2022
Q2
$5.78M Buy
1,178,956
+70,532
+6% +$346K ﹤0.01% 3629
2022
Q1
$26.2M Buy
1,108,424
+1,018,874
+1,138% +$24.1M ﹤0.01% 1836
2021
Q4
$1.58M Buy
89,550
+4,539
+5% +$80.3K ﹤0.01% 4748
2021
Q3
$2.4M Buy
85,011
+12,715
+18% +$359K ﹤0.01% 4414
2021
Q2
$757K Buy
72,296
+4,491
+7% +$47K ﹤0.01% 5247
2021
Q1
$799K Sell
67,805
-31,093
-31% -$366K ﹤0.01% 4863
2020
Q4
$1.16M Buy
98,898
+67,249
+212% +$787K ﹤0.01% 4579
2020
Q3
$251K Sell
31,649
-9,401
-23% -$74.6K ﹤0.01% 4987
2020
Q2
$751K Buy
41,050
+11,902
+41% +$218K ﹤0.01% 4375
2020
Q1
$348K Buy
29,148
+15,532
+114% +$185K ﹤0.01% 4584
2019
Q4
$226K Buy
13,616
+10,163
+294% +$169K ﹤0.01% 5363
2019
Q3
$23K Buy
+3,453
New +$23K ﹤0.01% 5963